SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Chavez-Blanco A.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:26
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer (2024)
 
2.- Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals (2024)
 
3.-

Hereditary diffuse gastric cancer (HDGC). An overview

(2022)
 
4.- BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal (2022)
 
5.- Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications (2022)
 
6.- Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy (2021)
 
7.- Targeting breast cancer cells with g4 pamam dendrimers and valproic acid derivative complexes (2020)
 
8.- Growth inhibition and transcriptional effects of ribavirin in lymphoma (2019)
 
9.- A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells (2019)
 
10.- Genital association of human papillomavirus with Mycoplasma and Ureaplasma spp. in Mexican women with precancerous lesions (2019)
 
11.- Advancing clinical research globally: Cervical cancer research network from Mexico (2018)
 
12.- Ivermectin as an inhibitor of cancer stem-like cells (2018)
 
13.- Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells (2018)
 
14.- Prevalence of sexually transmitted pathogens associated with HPV infection in cervical samples in a Mexican population (2015)
 
15.- Differential activation of dendritic cells by Mycobacterium tuberculosis Beijing genotype (2014)
 
16.- A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors (2007)
 
17.- A proof-of-principle study of epigenetics therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer (2006)
 
18.- Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines (2006)
 
19.- Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine (2006)
 
20.- Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer (2006)
 
21.- A phase I study of hydralazine to demythylate and reactivate the expression of tumor suppressor genes (2005)
 
22.- Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study (2005)
 
23.- HER2 expression in cervical cancer as a potential therapeutic target (2004)
 
24.- Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients (2003)
 
25.- Neuroendocrine marker expression in cervical carcinomas of non-small cell type (2002)
 
26.- A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma: Preliminary report (2002)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.